ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980